Compounds having the following structure
wherein R
1
, R
2
, R
3
, R
4
, m and n are as defined in the specification, in vivo-hydrolysable precursors thereof, pharmaceutically-acceptable salts thereof, the use in therapy and pharmaceutical compositions and methods of treatment using the same.